Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?
Autor: | Vis, André N., van der Sluis, Tim M., Al-Itejawi, Hoda H.M., van Moorselaar, R. Jeroen A., Meuleman, Eric J.H. |
---|---|
Zdroj: | In Urologic Oncology: Seminars and Original Investigations January 2015 33(1):7-15 |
Databáze: | ScienceDirect |
Externí odkaz: |